XNAS: RNTX
Rein Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, ...
Read More
1.03
-0.33
(-24.26%)
11.9M
XNAS Volume
High volume+loss today
XNAS 01 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Rein Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..